Improving sleep and quality of life in patients with idiopathic interstitial pneumonia, using nocturnal supplemental oxyge

Not Applicable

Completed

• Conditions: Idiopathic interstitial pneumonia; Interstitial lung disease; Respiratory - Other respiratory disorders / diseases

• Registration Number: ACTRN12611001286932
• Lead Sponsor: Royal Prince Alfred Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-12-15
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients 18 - 80 yrs.
Patients able to perform a polysomnogram (sleep study), as determined following clinical assessment.
Patients with nocturnal hypoxaemia, defined as >10% of the night with SpO2 <90% on overnight oximetry or PSG
Patients able to give informed consent.
Patients with idiopathic interstitial pneumonia (IIP), according to American Thoracic Society /European Respiratory Society criteria.
Absence of daytime resting hypoxaemia (ie with PaO2 > 55mmHg).

Exclusion Criteria

Patients <18yrs or >80yrs.
Patients not able to give informed consent.
Patients considered unable to complete a PSG by their physician.
Presence of daytime resting hypoxaemia (PaO2 less than or equal to 55mmHg).
Presence of hypercapnia (PaCO2 > 45mmHg) at baseline
Patients who do not meet oxygen saturation criteria for nocturnal hypoxaemia
Patients with co-existent obstructive sleep apnoea with apnoea hypopnoea index greater than or equal to 15 with clinical symptoms, or apnoea hypopnoea index greater than or equal to 30 (without symptoms)
Patients who are current smokers

Study & Design

• Study Type: Interventional
• Study Design: Not specified